Jainal Bhuiyan left the role of Director at Biotricity Inc., effective September 22, 2026. As of November 6, 2026, Biotricity Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on September 28, 2026, naming 1 departure (Form 8-K, September 28, 2026).
BIOTRICITY INC. announced the departure of its Director on Sep 28. 30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Biotricity Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Biotricity Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-28. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Biotricity Inc. files it.
Also on the record for Biotricity Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by Ionic Ventures, LLC | 9.9% of the class | 5%+ stakes | Source |
| May 12, 2026 | Stake report, Schedule 13G/A, by Ionic Ventures, LLC | 9.9% of the class | 5%+ stakes | Source |
| February 4, 2026 | Stake report, Schedule 13G/A, by Ionic Ventures, LLC | 9.9% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Ionic Ventures, LLC | 9.9% of the class | 5%+ stakes | Source |
| August 12, 2025 | Stake report, Schedule 13G/A, by Ionic Ventures, LLC | 9.9% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Biotricity Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Biotricity Inc. and the records around it.
Biotricity Inc. elsewhere on the record
Companies that share a holder
- Ionic Ventures, LLC also filed stake reports on 3 other companies: Algorhythm Holdings, Inc. (May 2026), Jet.AI Inc. (May 2026)
Watch Biotricity Inc.
Get an email when Biotricity Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Biotricity Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Biotricity Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biotricity Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-28 | Out | Director | 2026-09-22 | 8-K, 2026-09-28 |
Who leads Biotricity Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Jainal Bhuiyan, departure reported, effective 2026-09-22 (filed 2026-09-28). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Biotricity Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Biotricity Inc., with the record behind each one.
Find candidates like Director at Biotricity Inc.Every change, in the filing's words
Departing: Jainal Bhuiyan, Director, effective 2026-09-22
On September 22, 2026, Jainal Bhuiyan notified the Board of Directors (the "Board") of Biotricity Inc. (the "Company") of his resignation as a member of the Board and as a member of the Compensation Committee of the Board, effective September 22, 2026.
- Mr. Bhuiyan's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- Mr. Bhuiyan had served as a director of the Company since August 15, 2024.
- The Board thanks Mr. Bhuiyan for his service and contributions to the Company.
- Following Mr. Bhuiyan's resignation, the Board consists of three directors: Waqaas Al-Siddiq, David A. Rosa and Ronald McClurg.
- The Board has appointed Ronald McClurg to the Compensation Committee to fill the committee vacancy created by Mr. Bhuiyan's resignation.
- As a result, the Compensation Committee consists of David A. Rosa, who continues to serve as its chairman, and Ronald McClurg.
- The composition of the Audit Committee (Ronald McClurg, chairman, and David A. Rosa) and the Nominating and Corporate Governance Committee (David A. Rosa, chairman, and Ronald McClurg) is unchanged.
- The Board has not yet determined whether it will fill the vacancy on the Board created by Mr. Bhuiyan's resignation or reduce the size of the Board.
Tools for this story
Each opens in a new tab, filled in for Biotricity Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.